Response Rates
Showing 1 - 25 of >10,000
Lung Cancer Trial in Philadelphia (Framed Introductory Message A, Framed Introductory Message B, Framed Introductory Message C)
Recruiting
- Lung Cancer
- Framed Introductory Message A
- +5 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 25, 2023
Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastroesophageal Junction Carcinoma Trial in United States
Not yet recruiting
- Esophageal Adenocarcinoma
- +2 more
-
Palo Alto, California
- +5 more
Jan 12, 2023
Esophagus Adenocarcinoma, Esophagus Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Dallas
Recruiting
- Esophagus Adenocarcinoma
- +2 more
-
Dallas, TexasDallas VA Medical Center
Nov 2, 2021
Breast Cancer Trial (Physical training)
Not yet recruiting
- Breast Cancer
- Physical training
- (no location specified)
Jan 7, 2022
Rates to Radiation Alone or With Chemo In Head & Neck Cancer
Completed
- Larynx Cancer
- +4 more
-
Lexington, KentuckyMarkey Cancer Center
Jul 12, 2021
Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI
Active, not recruiting
- Safety and Tolerability
- +3 more
- Zoster Vaccine Recombinant, Adjuvanted
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2022
Vasovagal Syncope Trial in Calgary (Pacing)
Recruiting
- Vasovagal Syncope
- Pacing
-
Calgary, Alberta, CanadaUniversity of Calgary
Feb 7, 2022
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in Los Angeles (Durvalumab, Radiation Therapy, Carboplatin)
Withdrawn
- Breast Cancer
- Triple Negative Breast Cancer
- Durvalumab
- +3 more
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Aug 19, 2021
Ketosis, Metabolic Trial in Toronto (Study diet, Low glycemic index treatment diet)
Recruiting
- Ketosis, Metabolic
- Study diet
- Low glycemic index treatment diet
-
Toronto, Ontario, CanadaTornto General Hospital, UHN
Nov 1, 2021
Muscle Protein Synthesis Trial in Exeter (Bolus ingestion of protein)
Recruiting
- Muscle Protein Synthesis
- Bolus ingestion of protein
-
Exeter, United KingdomUniversity of Exeter
Jan 24, 2022
Colorectal Tumors Trial in São Paulo (Folfirinox)
Recruiting
- Colorectal Neoplasms
-
São Paulo, BrazilHospital Municipal Vila Santa Catarina
Oct 5, 2021
Bulimia Nervosa, Binge Eating Disorder Trial in Hamilton (Visual feedback of symptom frequency)
Active, not recruiting
- Bulimia Nervosa
- Binge Eating Disorder
- Visual feedback of symptom frequency
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare
Mar 22, 2021
Diabetes Trial in Leicester (Self Assessment, Electronic risk score)
Completed
- Diabetes
- Self Assessment
- Electronic risk score
-
Leicester, Leicestershire, United KingdomLeicester City PCT
Jan 29, 2020
Human Immunodeficiency Virus-type 1 Infection Trial in Worldwide (Rilpivirine, Efavirenz, Tenofovir disoproxil fumarate)
Completed
- Human Immunodeficiency Virus-type 1 Infection
- Rilpivirine
- +3 more
-
Douala, Cameroon
- +17 more
Jan 22, 2021
Colorectal Cancer Trial in Minneapolis (Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments
Completed
- Colorectal Cancer
- Use of Interactive Voice Response (IVR) system to improve adherence to GI appointments and prep procedures
-
Minneapolis, MinnesotaMinneapolis VA Health Care System, Minneapolis, MN
Jun 15, 2020
Urothelial Bladder Carcinoma Trial in Spain (Sacituzumab govitecan, Zimberelimab, Domvanalimab)
Not yet recruiting
- Urothelial Bladder Carcinoma
- Sacituzumab govitecan
- +2 more
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Nov 14, 2023
Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Dasatinib Pill
- Ketoconazole Pill
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. José Eleuterio González
Nov 25, 2022
Triple-negative Breast Cancer Trial (Taxane and Carboplatin, Short-term Sintilimab, Surgery)
Not yet recruiting
- Triple-negative Breast Cancer
- Taxane and Carboplatin
- +2 more
- (no location specified)
Apr 25, 2023